CORE LABORATORIES N.V. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2011-10-20: Form 8-K; Period of report 2011-10-19; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2011-10-19: Form 8-K; Period of report 2011-10-19; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2011-10-11: Form 8-K; Period of report 2011-10-11; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2011-09-30: Form 8-K; Period of report 2011-09-28; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2011-10-20 | 8-K | 2011-10-19 | 2.02 Results of Operations and Financial Condition | 2.02 On October 19, 2011, Core Laboratories N.V. issued a press release announcing its financial results for the third quarter of 2011 and year-to-date as of September 30, 2011. | clb-2011q3_earningsreleasea.htm |
| 2011-10-19 | 8-K | 2011-10-19 | 2.02 Results of Operations and Financial Condition | 2.02 On October 19, 2011, Core Laboratories N.V. issued a press release announcing its financial results for the third quarter of 2011 and year-to-date as of September 30, 2011. | clb-2011q3_earningsrelease.htm |
| 2011-10-11 | 8-K | 2011-10-11 | 7.01 Regulation FD Disclosure | 7.01 On October 11, 2011, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.25 per share of common stock for shareholders of record on October 21, 2011 and payable November 22, 2011. | clb-8k_dividend.htm |
| 2011-09-30 | 8-K | 2011-09-28 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 On September 28, 2011, Core Laboratories N.V. and Core Laboratories LP, entered into an Assignment, Assumption and Amendment to Credit Agreement related to their Fifth Amended and Restated Credit Agreement (henceforth referred to as the “Amended Credit Agreement”) with various financial institutions which are parties to the Amended Credit Agreement (collectively, the “Lenders”), and Bank of America, N.A. as administrative agent for the Lenders and as a letter of credit issuing bank. | a8k_clb-debtannouncement.htm |
| 2011-09-06 | 8-K | 2011-08-30 | 1.01 Entry into a Material Definitive Agreement | 1.01 On August 30, 2011, Core Laboratories N. V. (“Core”) entered into a fourth amendment (the “Fourth Warrant Amendment”) to its Warrant Confirmation dated October 31, 2006 and Warrant Confirmation Amendment dated November 15, 2006 (the “Confirmations”), with Citibank, N.A. in order to accelerate the settlement of the final portion of the warrants. | a8-kfourthwarrantagreement.htm |
| 2011-08-10 | 8-K/A | 2011-05-25 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 At the Company's Annual Meeting, shareholders were asked to consider and act upon, among other matters, an advisory vote on the frequency of an advisory vote on executive compensation. | clb-8ka_boardapproval.htm |
| 2011-08-08 | 8-K | 2011-08-02 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 On August 2, 2011, Core Laboratories N. V. (“Core”) entered into a third amendment (the “Third Warrant Amendment”) to its Warrant Confirmation dated October 31, 2006 and Warrant Confirmation Amendment dated November 15, 2006 (the “Confirmations”), with Citibank, N.A. in order to accelerate the settlement of another portion of the warrants. 3.02 The information set forth under Item 1.01 above is incorporated herein by reference. | a8-kthirdwarrantamendmenta.htm |
| 2011-07-20 | 8-K | 2011-07-20 | 2.02 Results of Operations and Financial Condition | 2.02 On July 20, 2011, Core Laboratories N.V. issued a press release announcing its financial results for the second quarter of 2011 and year-to-date as of June 30, 2011. | clb-2011q2_earningsrelease.htm |
| 2011-07-12 | 8-K | 2011-07-12 | 7.01 Regulation FD Disclosure | 7.01 On July 12, 2011, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.25 per share of common stock for shareholders of record on July 22, 2011 and payable August 22, 2011. | clb-8k_dividend2011q3.htm |
| 2011-06-09 | 8-K | 2011-06-06 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 On June 6, 2011, Core Laboratories N. V. (“Core”) entered into a second amendment (the “Second Warrant Amendment”) to its Warrant Confirmation dated October 31, 2006 and Warrant Confirmation Amendment dated November 15, 2006 (the “Confirmations”), with Citibank, N.A. in order to accelerate the settlement of another portion of the warrants. 3.02 The information set forth under Item 1.01 above is incorporated herein by reference. | a8-k.htm |
| 2011-05-25 | 8-K | 2011-05-19 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 Core Laboratories N.V. (the “Company”) held its Annual Meeting of Shareholders (the “Annual Meeting”) on May 19, 2011. | h82599e8vk.htm |
| 2011-05-10 | 8-K | 2011-05-04 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 On May 4, 2011, Core Laboratories N. V. entered into an amendment (the “Warrant Amendment”) to its Warrant Confirmation dated October 31, 2006 and Warrant Confirmation Amendment dated November 15, 2006 (the “Confirmations”), with Citibank, N.A. in order to accelerate the settlement of a portion of the warrants. 3.02 The information set forth under Item 1.01 above is incorporated herein by reference. | h82195e8vk.htm |
| 2011-04-21 | 8-K | 2011-04-19 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 On April 19, 2011, Core Laboratories N.V. and Core Laboratories LP amended its Fifth Amended and Restated Credit Agreement (henceforth referred to as the “Amended Credit Agreement”) with various financial institutions which are parties to the Amended Credit Agreement (collectively, the “Lenders”), and Bank of America, N.A. as administrative agent for the Lenders and as a letter of credit issuing bank. 2.03 The information set forth under Item 1.01 above is incorporated herein by reference. | clb-8k_creditagreement.htm |
| 2011-04-19 | 8-K | 2011-03-31 | 2.02 Results of Operations and Financial Condition | 2.02 On April 19, 2011, Core Laboratories N.V. issued a press release announcing its financial results for the first quarter of 2011. | clb-q1_earningsrelease.htm |
| 2011-04-18 | 8-K | 2011-04-18 | 7.01 Regulation FD Disclosure | 7.01 On April 18, 2011, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.25 per share of common stock for shareholders of record on April 28, 2011 and payable May 27, 2011. | clb-8k_dividend.htm |
| 2011-04-04 | 8-K | 2011-03-30 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 As previously announced, on March 2, 2011, the Board of Supervisory Directors of Core Laboratories N.V. (the “Company”) approved a Board Succession Plan whereby one non-employee supervisory director will be replaced with a new supervisory director each year for the next six years. | clb-8k_april4.htm |
| 2011-03-15 | 8-K | 2011-03-15 | 7.01 Regulation FD Disclosure | 7.01 Core Laboratories N.V. reported that colder than average temperatures in North America created delays to expected client activity in January and February 2011. | clb-8k_disclosure.htm |
| 2011-03-07 | 8-K | 2011-03-02 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 2, 2011, the Supervisory Board of Directors of Core Laboratories N.V. approved a Board Succession Plan. | clb-8k_successionplan.htm |
| 2011-02-09 | 8-K | 2010-12-31 | 2.02 Results of Operations and Financial Condition | 2.02 On February 9, 2011, Core Laboratories N.V. issued a press release announcing its financial results for the fourth quarter of 2010 and full year ended December 31, 2010. | clb-8k_earningsrelease.htm |
| 2011-01-14 | 8-K | 2011-01-14 | 7.01 Regulation FD Disclosure | 7.01 On January 14, 2011, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.25 per share of common stock for shareholders of record on January 25, 2011 and payable February 25, 2011. | clb-8k_dividend.htm |